martes, 18 de junio de 2019

Akrevia Therapeutics eyes safer immunotherapies

Akrevia Therapeutics eyes safer immunotherapies

Cancer Briefing



STAT Plus: Startup Spotlight: Akrevia Therapeutics eyes safer immunotherapies

By KATE SHERIDAN


ALEX HOGAN/STAT
The startup is hoping it can find new drugs that mimic the effects of immunotherapies but without sending the immune system into overdrive.

No hay comentarios: